Schizophrenia: The occurrence of discontinuation as a result of damaging responses for placebo-treated as well as quetiapine-treated individuals was 8.2 % as well as 2.7 %, specifically. The unfavorable occasion bring about discontinuation in 1 % or more of individuals on Seroquel and also at a higher occurrence than sugar pill was somnolence (2.7 % and also 0 % for sugar pill).
Bipolar I Mania: The incidence of discontinuation due to adverse responses for quetiapine-treated and placebo-treated people was 11.4 % and 4.4 %, respectively. The unfavorable reactions leading to discontinuation in 2 % or more of people on Seroquel as well as at a better occurrence compared to sugar pill were somnolence (4.1 % vs. 1.1 %) as well as exhaustion (2.1 % vs.
In treatment for schizophrenia (up to 6 weeks), the most generally noted unfavorable responses connected regarding the usage of quetiapine in teenagers (incidence of 5 % or better and also quetiapine occurrence at the very least two times that for placebo) were somnolence (34 %), dizziness (12 %), dry mouth (7 %), tachycardia (7 %).
In bipolar mania treatment (up to 3 weeks) one of the most generally observed negative reactions associated with using quetiapine in adolescents as well as children (occurrence of 5 % or better and quetiapine occurrence at the very least twice that for placebo) were somnolence (53 %), lightheadedness (18 %), tiredness (11 %), increased appetite (9 %), queasiness (8 %), vomiting (8 %), tachycardia (7 %), completely dry mouth (7 %), and also weight boosted (6 %).